AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Specimen Collection Study for Cancer
Sponsor: Freenome Holdings Inc.
A observational or N/A phase clinical study on Adenoma and Adenoma Colon, this trial is completed. The trial is conducted by Freenome Holdings Inc. and has accumulated 10 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Apr 2022 [monthly]
Completed
-
Aug 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2020 — Aug 2020 [monthly]
Completed
-
Mar 2020 — Jun 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2019 — Mar 2020 [monthly]
Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Recruiting
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Freenome Holdings Inc.
For direct contact, visit the study record on ClinicalTrials.gov .